Member access

4-Traders Homepage  >  Shares  >  Nyse  >  Sanofi SA    SNY   US80105N1054

SANOFI SA (SNY)

7
SummaryQuotesChart AnalysisNewsCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Logo Sanofi SA
Engages in the research, production and distribution of pharmaceutical products

Sanofi engages in the research, production and distribution of pharmaceutical products.

The company operates through the following segments: Pharmaceuticals, Human Vaccines and Animal Health.

The Pharmaceuticals segment includes research, development, production and sales activities relating to pharmaceutical products, including prescription, consumer health care, and generic products.

This segment also includes equity affiliates and joint ventures with pharmaceutical business activities.

The Human Vaccines segment includes research, development, production and marketing.

The Animal Health segment comprises the research, development, production and marketing activities for vaccines.

It offers a range of medicines and vaccines on animal species.

The company was founded in 1994 and is headquartered in Paris, France.
Sales per Businesses
20122013Delta
USD (in Million)%USD (in Million)%
Pharmaceuticals37,29482.6%36,24782.7% -2.89%
Vaccines5,03411.2%4,94311.3% -1.84%
Animal Health2,8156.2%2,6406% -6.6%
Sales per Regions
20122013Delta
USD (in Million)%USD (in Million)%
Rest of the World16,08435.6%15,21934.7% -5.68%
United States14,04531.1%13,87831.7% -1.21%
Europe10,60523.5%10,55224.1% -0.5%
France3,6768.1%3,4207.8% -7.5%
North America732.421.6%762.191.7% +3.91%
Officers and Executives
NameAgeOfficer SinceTitle
Christopher A. Viehbacher, CPA542008Chief Executive Officer & Director
Serge Weinberg632009Chairman
Jérôme Contamine562009Chief Financial Officer & Executive Vice President
Elias Adam E. Zerhouni, MD632010President-Global Research & Development
Bruno Ménard-2011Chief Information Officer
Jorge Insuasty, MD-2011VP, Deputy President-Research & Development
Ji Zhang, PhD-2003Head-Research & Development Scientific Platforms
Gary J. Nabel MD, PhD-2012Chief Scientific Officer & Senior Vice President
Paul Chew, PhD-2013Chief Medical Officer & Senior Vice President
Igor Landau, MBA702004Member-Supervisory Board
Surperformance© rating of Sanofi SA
Overall rating In sector In country
Trading Rating
Investor Rating
Growth (Revenue)
Valuation
Finances
Profitability
Earnings quality
Business Predictability
PER
Potential
Yield
Consensus
7 days EPS revision
4 months EPS revision
1 year EPS revision
4 months Revenue revision
1 year Revenue revision
More Ratings
Sector
Healthcare
Biotechnology / Pharmaceuticals
 Biotechnology / Pharmaceuticals
  Pharmaceuticals - Diversified
Advertisement
Sector Pharmaceuticals - Diversified
Trading RatingInvestor Rating
JOHNSON & JOHNSON
ROCHE HOLDING LTD..
NOVARTIS AG
PFIZER INC.
MERCK & CO., INC.
Sector Pharmaceuticals - Diversified
Company contact information
Sanofi
54, rue La Boétie
8ème arrondissement
Paris, Ile-de-France 75008

Phone : +33.1.53.77.40.00
Fax : +33.1.53.77.43.03
Web : www.sanofi.com
© 2014 Factset   
Dynamic quotes  
ON
| OFF